PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1808875
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1808875
Intubation Tubes Market size was valued at US$ 2,830.25 Million in 2024, expanding at a CAGR of 6.90% from 2025 to 2032.
The Intubation Tubes Market involves medical devices inserted into the trachea to maintain airway patency, especially during surgeries or emergency interventions. Demand is increasing due to the rising incidence of respiratory diseases, trauma cases, and surgeries requiring general anesthesia. The growing geriatric population and high ICU admissions, especially in post-pandemic healthcare systems, are strengthening adoption. However, complications like airway injuries, post-extubation hoarseness, and risks of infections are key concerns limiting widespread acceptance. On the opportunity side, healthcare infrastructure development in the Asia-Pacific and government investments in critical care capacity are opening new avenues. For instance, India's 2024 "Critical Care Equipment Scheme" supports local manufacturing of essential airway management devices.
Intubation Tubes Market- Market Dynamics
Rising Surgical Procedures and Respiratory Cases Propel Intubation Tubes Market Expansion
The increasing volume of surgical procedures and the growing burden of respiratory conditions are significantly driving the intubation tubes market. According to the World Health Organization (WHO), chronic respiratory diseases affected over 262 million people globally in 2023, pushing demand for airway management tools in both emergency and elective care. The U.S. Centers for Medicare & Medicaid Services (CMS) noted a rise in inpatient procedures involving general anesthesia, further amplifying intubation tube usage in operating rooms. Moreover, post-COVID emphasis on ICU preparedness and ventilator support has led to strategic investments in airway consumables across public health systems. For instance, in 2024, the UK's NHS invested in scalable intubation kits for pandemic preparedness. In India, AIIMS hospitals adopted new-generation reinforced endotracheal tubes for enhanced safety during prolonged intubation. These evolving clinical practices are creating long-term growth opportunities, especially as portable ventilator adoption increases across ambulatory settings.
Intubation Tubes Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.90% over the forecast period (2025-2032)
Based on product type segmentation, Trachea intubation was predicted to show maximum market share in the year 2024
Based on Material segmentation, Polyvinyl Chloride (PVC) was the leading Material in 2024
Based on Application segmentation, General Anesthesia was the leading Application in 2024
On the basis of region, North America was the leading revenue generator in 2024
The Global Intubation Tubes Market is segmented on the basis of Product Type, Material, Application, End-User, and Region.
The market is divided into two categories based on product type: Trachea Intubation (Endotracheal Intubation, Nasotracheal Intubation, Orotracheal Intubation), Gastric Intubation (Orogastric Intubation, Nasogastric Intubation), and Others. Trachea intubation leads the market, with endotracheal intubation being the most preferred due to its frequent use in surgeries and emergency care. It is followed by gastric intubation methods, while the "Others" segment holds the least market share.
The market is divided into four categories based on Material: Polyvinyl Chloride (PVC), Silicone, Polyurethane, and Rubber. Polyvinyl Chloride (PVC) dominates the market due to its cost-effectiveness and flexibility, making it the most widely used material for intubation tubes. Silicone and polyurethane follow for their biocompatibility, while rubber holds a minimal share due to limited modern usage.
Intubation Tubes Market- Geographical Insights
North America dominates the intubation tubes market, supported by strong ICU infrastructure and a high volume of surgical procedures. For example, the U.S. CDC reported approximately 51.4 million hospital inpatient surgeries in 2023, many of which require airway management. In Europe, WHO data highlights that chronic obstructive pulmonary disease (COPD) affects over 36,580,965 individuals, increasing the use of intubation in critical care settings. The Asia-Pacific region is witnessing rapid growth: India's Ministry of Health has been actively strengthening public healthcare infrastructure, particularly in rural areas, through various initiatives like expanding Ayushman Arogya Mandirs and providing technical and financial support to states, while China's National Health Commission has been planning to increase ICU bed capacity over the years. In Latin America, Brazil's Ministry of Health registered over 9,502,378 hospitalizations due to RD, fueling demand for emergency airway equipment. These region-specific health statistics illustrate strong support-driven expansion in the global market.
Major global players dominate this market, with Medtronic, Teleflex Incorporated, Smiths Medical, Vyaire Medical, and ConvaTec leading innovation and product portfolios. Medtronic commands about 20-25% of the market through advanced cuff technologies and airway systems, while Teleflex holds around 15-20%, focusing on reinforced and specialty tubes, and Smiths Medical holds roughly 12-16%, particularly in antimicrobial-coated options. In August 2022, Teleflex further expanded its interventional offerings by acquiring Vesper Medical, enhancing its video laryngoscope-based airway visualization capabilities. Medtronic also bolstered its critical care portfolio in September 2023 by acquiring Curon Medical, known for innovative tracheostomy tubes and airway accessories. Additionally, in May 2021, Olympus secured FDA clearance for its Airway Mobilescopes portable video-supported intubation tools, strengthening its presence in critical-care airway management. These strategic moves signal a competitive landscape driven by innovation, consolidation, and expanded clinical solutions.
In June 2025, USDA-ARS researchers developed an allergy-safe guayule latex cuff for endotracheal tubes, replacing traditional PVC cuffs to reduce ventilator-associated pneumonia since 8-28% of ventilated patients develop this infection, offering enhanced seal and allergy protection.
In April 2024, Asahi Kasei Medical entered an exclusive agreement to distribute AW Technologies' TrachFlush(R) device in Japan, targeting a fiscal 2024 launch. The innovative airway secretion management tool, already CE Marked and FDA-cleared, offers automated cuff deflation/inflation synchronized with ventilator cycles, enhancing ICU patient comfort and reducing suction frequency.
In June 2023, Teleflex Incorporated issued a global recall of specific Rusch endotracheal tubes manufactured between January 2018 and April 2023 due to 189 reports of connector disconnections resulting in nine patient desaturation events and four deaths under a Class I FDA safety alert.